Cardio Diagnostics Inc.
CDIO | NASDAQ
$1.92
-$0.10 (-4.95%)
At close: Sep 21, 2026, 4:00 PM ET
$2
+$0.08 (+4.17%)
After-hours:
Sep 21, 2026, 7:04 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 14.83K | 34.89K | 17.07K | 950 | 901 | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 14.83K | 34.89K | 17.07K | 950 | 901 | n/a |
Operating Income | -6.48M | -8.37M | -7.24M | -4.55M | -620.45K | -609.16K |
Interest Income | 712 | 1.06K | 1.07K | n/a | n/a | n/a |
Pretax Income | -6.5M | -8.38M | -8.38M | -4.66M | -620.45K | -605.16K |
Net Income | -6.5M | -8.38M | -8.38M | -4.66M | -620.45K | -605.16K |
Selling & General & Admin | 5.79M | 8.15M | 7.1M | 4.49M | 573.88K | 597K |
Research & Development | 641.21K | 227.97K | 145.18K | 40.45K | 31.47K | 1.5K |
Other Expenses | 65.23K | 19.74K | 19.18K | 16K | 16K | 10.67K |
Operating Expenses | 6.5M | 8.4M | 7.26M | 4.55M | 621.35K | 609.16K |
Interest Expense | 14.8K | 18.64K | 6.74M | n/a | n/a | n/a |
Selling & Marketing Expenses | 766.89K | 1.23M | 158.51K | 92.7K | 103.32K | 5.48K |
Cost & Expenses | 6.5M | 8.4M | 7.26M | 4.55M | 621.35K | 609.16K |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 1.75M | 26.89M | 422.84K | 3.09M | 317.16K | 9.52M |
Shares Outstanding (Diluted) | 1.75M | 26.89M | 422.84K | 3.09M | 317.16K | 9.52M |
EPS (Basic) | -3.71 | -9.30 | -19.80 | -45.30 | -1.96 | -0.06 |
EPS (Diluted) | -3.71 | -9.30 | -19.80 | -45.30 | -1.96 | -0.06 |
EBITDA | -6.09M | -8.09M | -1.53M | -4.64M | -604.45K | -598.5K |
EBIT | -6.48M | -8.36M | -1.64M | -4.66M | -620.45K | -609.16K |
Depreciation & Amortization | 398.13K | 276.35K | 111.62K | 16K | 16K | 10.67K |
Add to Watchlist
Select watchlists to add or remove CDIO